The easiest way to email your members of Congress
Donate Now
You are writing regarding
H.R.3988 has been viewed 3,727 times
H.R.3988 Generic Drug and Biosimilar User Fee Act of 2012, 112th Congress
Sponsor: Rep. Tim Murphy [R, PA-18]Contact Congress
1.
Choose Your Position
2.
Write Your Letter
3.
Share Your Communication
OpenCongress Message Builder
OpenCongress Message Builder
Use the tools in this column to help craft your letter. Anytime your mouse highlights a section, click on it to add prepared text. You can edit any part of the message at left, and if you like, add your own stories and text to personalize your letter.
Official Bill Info
-
Latest Action: Feb 10, 2012
Referred to the Subcommittee on Health.
Clicking this will add the following text:
I know the most recent action for this bill is as follows: "Referred to the Subcommittee on Health." on Feb 10, 2012 -
Committee Assignment:
House Energy and Commerce
Clicking this will add the following text:
This bill has been assigned to the House Energy and Commerce committee. -
Committee Assignment:
House Energy and Commerce - Health
Clicking this will add the following text:
This bill has been assigned to the House Energy and Commerce - Health committee.
Bill Statistics on OpenCongress
Clicking this will add the following text:
H.R.3988 has been viewed 3,727 times on OpenCongress.org, a free, non-partisan resource.
Contribution Data
Enter your street address above, and relevant campaign contribution data for your elected officials will appear here in seconds for you to use in your letter.
Most-commented sections of the bill text
Highest Rated User Comments
Highly Rated Blog Articles
-
Rep. Murphy's Drug Bill Nears Approval - Baldwin-Whitehall, PA Patch
-
June 22, 2012
by
Andrea Bosco
-
Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ...
Clicking this will add the following text:
As noted by Andrea Bosco on June 22, 2012, "Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ..." (/url?q=http://baldwin-whitehall.patch.com/articles/rep-murphys-drug-bill-nears-approval&sa=U&ei=dHfsT4voG-XE2gXR_a3AAQ&ved=0CDEQmAEwBQ&usg=AFQjCNF_5OJN8v8ncwqVsPWZi_59Z6r3vA) -
Rep. Murphy's Drug Bill Nears Approval - Baldwin-Whitehall, PA Patch
-
June 22, 2012
by
Andrea Bosco
-
Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ...
Clicking this will add the following text:
As noted by Andrea Bosco on June 22, 2012, "Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ..." (/url?q=http://baldwin-whitehall.patch.com/articles/rep-murphys-drug-bill-nears-approval&sa=U&ei=xxXrT9mKE4Ss2wWE_6GwAQ&ved=0CDEQmAEwBQ&usg=AFQjCNEUHliO1-1PQ6junlsHRXzHpkyZDg) -
Rep. Murphy's Drug Bill Nears Approval - Baldwin-Whitehall, PA Patch
-
June 22, 2012
by
Andrea Bosco
-
Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ...
Clicking this will add the following text:
As noted by Andrea Bosco on June 22, 2012, "Murphy's legislation, the Generic Drug and Biosimilar User Fee Act of 2012 (H.R. 3988), clears a backlog of 2800 generic applications awaiting FDA review and factory inspection. His bill will provide the resources needed for ..." (/url?q=http://baldwin-whitehall.patch.com/articles/rep-murphys-drug-bill-nears-approval&sa=U&ei=acfpT6jlCOGA2gW17-X9CA&ved=0CC0QmAEwBA&usg=AFQjCNGxOGwKrKvVA44p8Cd06ZWP0xeT-Q)
Highly Rated News Articles
-
This new drug law will save money and patients' lives
-
July 25, 2012
by
Pittsburgh Post-Gazette
-
I authored legislation called the Generic Drug and Biosimilar User Fee Act (H.R. 3988), which was just signed into law by President Barack Obama, to further advance access to generic medications. In addition to putting foreign factories under the same ...
Clicking this will add the following text:
As noted by Pittsburgh Post-Gazette on July 25, 2012, "I authored legislation called the Generic Drug and Biosimilar User Fee Act (H.R. 3988), which was just signed into law by President Barack Obama, to further advance access to generic medications. In addition to putting foreign factories under the same ..." (http://www.post-gazette.com/stories/opinion/letters/this-new-drug-law-will-save-money-and-patients-lives-646073/) -
Making Safe Prescription Drugs More Affordable and Accessible
-
July 12, 2012
by
Patch
-
To break down these obstacles and ensure a safe and swift FDA process, I introduced the Generic Drug and Biosimilar User Fee Act (H.R. 3988). In addition to putting foreign factories under the same rigorous inspection regime as domestic plants ...
Clicking this will add the following text:
As noted by Patch on July 12, 2012, "To break down these obstacles and ensure a safe and swift FDA process, I introduced the Generic Drug and Biosimilar User Fee Act (H.R. 3988). In addition to putting foreign factories under the same rigorous inspection regime as domestic plants ..." (http://chartiersvalley.patch.com/blog_posts/making-safe-prescription-drugs-more-affordable-and-accessible) -
Making Safe Prescription Drugs More Affordable and Accessible
-
July 12, 2012
by
Patch
-
To break down these obstacles and ensure a safe and swift FDA process, I introduced the Generic Drug and Biosimilar User Fee Act (H.R. 3988). In addition to putting foreign factories under the same rigorous inspection regime as domestic plants ...
Clicking this will add the following text:
As noted by Patch on July 12, 2012, "To break down these obstacles and ensure a safe and swift FDA process, I introduced the Generic Drug and Biosimilar User Fee Act (H.R. 3988). In addition to putting foreign factories under the same rigorous inspection regime as domestic plants ..." (http://baldwin-whitehall.patch.com/blog_posts/making-safe-prescription-drugs-more-affordable-and-accessible)
We are trying to send your message

Contact Congress




